Carfilzomib, lenalidomide, and dexamethasone compared with lenalidomide treatment after autologous haematopoietic stem-cell transplantation in patients with multiple myeloma (ATLAS): primary analysis ... The enhanced efficacy of carfilzomib–lenalidomide–dexamethasone treatment following autologous HSCT in patients with newly diagnosed multiple myeloma, assessed within a framework of de-escalation base...

New paper alert 🚨‼️

Our myeloma team and colleagues from across the glob have published their primary analysis of their Phase III ATLAS trial in @thelancet.com! Read it at www.thelancet.com/journals/lan...

#AtTheForefront #Myeloma #ClinicalTrials #CancerResearch #OncSky #MedSky

March is #ColorectalCancerAwarenessMonth! Make sure you know the best practices for preventing and screening for this cancer:

#AtTheForefront #ColorectalCancer #CancerCare #CancerTreatment #OncSky

Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer | NEJM Patients with muscle-invasive bladder cancer who are ineligible for cisplatin-based chemotherapy proceed directly to radical cystectomy with pelvic lymph-node dissection. Perioperative therapy may ...

Congratulations to Dr. O'Donnell who is a co-author in a new @nejm.org article about practice-changing findings that resulted in a new FDA approval for bladder cancer! Read it at www.nejm.org/doi/full/10....

#AtTheForefront #CancerCare #CancerResearch #OncSky

People live longer with cancer. That's good news, but ... | Opinion Better treatment and earlier diagnosis mean that 7 in 10 people will survive five years or more after a cancer diagnosis.

Dr. Smith has a new article on @usatoday.com about the importance of survivorship care for those who have had cancer, especially as research and care innovations have improved survival rates and longevity! Read her insights: www.usatoday.com/story/opinio...

#AtTheForefront #CancerCare

Post ASH Annual Meeting - Hematology University of Chicago Post ASH Annual Meeting - American Society of Hematology

TOMORROW!! If you haven't registered yet, there's still time to join our team for Post ASH!

More at www.chicagopostash.com

#AtTheForefront #PostASH #Hematology

Phase 1b Study of Dazostinag Plus Pembrolizumab After Hypofractionated Radiotherapy in Patients With Select Advanced Solid Tumors Abstract. Purpose: We present the preclinical rationale and clinical data from a phase 1b trial investigating the STING agonist dazostinag plus pembrolizumab following hypofractionated radiotherapy in...

New article alert!! 🚨

Drs. Olson & Chmura are senior authors on a new piece in @aacrjournals.bsky.social's Cancer Research Communications about results from their latest Phase 1b study for a variety of solid tumors! Read it at doi.org/10.1158/2767...

#AtTheForefront #CancerResearch #CancerCare

Fermenting T cell stemness for cancer immunity Gut microbial metabolites modulate immune responses to tumors. In this issue of Immunity, Bachem et al. demonstrate that microbiota-derived butyrate cooperates with the transcription factor Foxo1 to p...

What a week for new publications! Dr. Park has a new paper out in @cellpress.bsky.social Immunity about T cells! Read it at www.cell.com/immunity/ful...

#AtTheForefront #CancerImmunity #Tcells #OncSky

Potential alternative dosage strategies for patent-protected oral cancer drugs To identify potential alternative dosage strategies for patent-protected oral oncology drugs that could reduce costs without decreasing efficacy for f…

A new article on alternative dosing strategies for oral cancer meds is out now from Drs. Wesevich & Ratain! You can find it at: www.sciencedirect.com/science/arti...

#AtTheForefront #MedicationDosing #CancerTreatment #OncSky

#TBT to last weekend's South Side Science Festival!! Hosted on campus and open to community members of all ages, we spent the day celebrating science and curiosity!

#UniversityofChicago #AtTheForefront #medSky #ScienceIsForEveryone #EducationSky #OncSky

Our Chicago: Breast Cancer Awareness Month Breast cancer is the most common cancer in women here in the U.S., second only to skin cancers. For 2025, the American Cancer Society estimates that nearly 317 thousand new cases of invasive breast ca...

Our faculty in the media!! 👩‍⚕️👨‍⚕️

Dr. Chen is on @abc7chicago.bsky.social talking about #BreastCancerAwarenessMonth (abc7chicago.com/post/chicago...)
and
Dr. Sweis on @onclive.bsky.social sharing about a novel treatment approach to renal cell carcinoma (www.onclive.com/view/dual-bi...)

#AtTheForefront

Challenge.gov Challenge.gov is the official government website supporting prize challenges and prize competitions that are sponsored by the US federal government. Here federal agencies provide prize awards to publi...

Congratulations to the UChicago/Infleqtion team who were recently announced as a Phase 1 winner for the NIH Quantum Sensing Technology Challenge!! Learn more about their project at www.challenge.gov?challenge=ni...

@uchicagomedicine.bsky.social

#AtTheForefront

UChicago Medicine hopes to expand its cancer care nationwide, announces first affiliation with Kansas hospital AdventHealth Cancer Institute Shawnee Mission in the Kansas City area will remain an independent entity but align with UChicago Medicine when it comes to standards in clinical care, medical educati…

More great coverage of our cancer work nationally in Kansas!! 🗺️⚕️

@chicagotribune.com : www.chicagotribune.com/2025/08/20/u...

@crainschicago.bsky.social : www.chicagobusiness.com/health-care/...

#AtTheForefront #CancerCare #OncSky

@adventhealth.bsky.social / @uchicagomedicine.bsky.social

Head and Neck Cancer | Medical Stories Mary Pat, an assistant at the University of Chicago, finally learned she had head and neck cancer, she dreaded what would come next.

A new Medical Stories segment is out/airing on @pbs.org featuring Dr. @arirosenbergmd.bsky.social & one of his patients (who is a former UChicago employee!!). It's a beautiful episode & definitely worth a watch! You can find it at medicalstories.tv/title/head-a...
#HeadNeckCancer #AtTheForefront

🚀 Let the countdown to Friday and the Developmental Therapeutics Symposium!! Visit www.uofcdevelopmentaltherapeuticssymposium.org to learn more, see the program schedule, and register!

#DevelopmentalTherapeutics #AtTheForefront #OncSky

Our @uchemoncfellows.bsky.social are doing a superb job presenting their research at today's Hem/Onc Clinical Postdoctoral Fellowship Retreat! Great to hear about their work and fast-building expertise and learn from external speakers!

#AtTheForefront #Oncology #Hematology #ClinicalTraining

Mark your calendars for May 2nd when the Developmental Therapeutics Symposium is back!! Directed by Dr. Odenike, it is sure to be a day of insights, new knowledge, and networking! Learn more at www.uofcdevelopmentaltherapeuticssymposium.org

#DevelopmentalTherapeutics #AtTheForefront

Ask the Doctor About Lymphoma: Information for Newly Diagnosed Patients - March 12, 2025 Ask the Doctor is a national series of two-hour, topic-specific, community-based programs that combine a presentation by a medical doctor.

One week from today: March 12, join the Lymphoma Research Foundation for a virtual "Ask the Doctor" featuring Dr. Riedell! Learn more and register at lymphoma.org/newdxatd1/ & pass along to your patients and community!!

#AtTheForefront #Lymphoma #CancerQuestions #OncSky

March is
🔹🔷 #ColorectalCancerAwarenessMonth 🔷🔹
Join our faculty & staff for some fascinating webinars throughout the month to learn more about where we are with treatment & prevention!

#AtTheForefront #CancerCare #OncSky

Tumor-Agnostic Therapies in Practice: Challenges, Innovations, and Future Perspectives This review comprehensively analyzes the current landscape of tumor-agnostic therapies in oncology. Tumor-agnostic therapies are designed to target specific molecular alterations rather than the prima...

Dr. Rajat Thawani and 2nd year Hem/Onc Fellow Dr. Sulin Wu are co-authors of a new paper in Cancers about the use of tumor-agnostic therapies. Read this great new piece at doi.org/10.3390/canc...

#AtTheForefront #CancerResearch #CancerCare #OncSky

Epigenomic exploration of disease status of EGFR‐mutated non‐small cell lung cancer using plasma cell‐free DNA hydroxymethylomes

Another new article out (‼️) featuring Drs. Garassino, Vokes, and Bestvina (Sr. author) + colleagues about EFGR-mutated NSCLC! Published in Cancer Communications: pmc.ncbi.nlm.nih.gov/articles/PMC...

#AtTheForefront #CancerResearch

IMPEACHMENT NI VP SARA, WALANG BENEPISYO SA TAUMBAYAN?

Rep. Bonifacio Bosita says the impeachment of VP Sara Duterte would bring no real benefit to the Filipino people if pursued by the Senate, in his exclusive interview with Atty. Karen Jimeno on #AtTheForefront.

A great new article out in @bloodportfolio.bsky.social with lead author Dr. Kline (& featuring many others from our Section including Dr. Smith) doi.org/10.1182/bloo...
and another featuring Dr. Derman in @nature.com www.nature.com/articles/s41...

#AtTheForefront #CancerResearch #OncSky

Co-directed by two of our incredible experts, Drs. Nanda and Chen, the Multidisciplinary Breast Cancer Symposium is tomorrow! Learn more/register at UChicagoBreastSymposium.com

#BreastCancer #AtTheForefront #CancerCare

January is #CervicalCancer Awareness Month. Prevention and early detection are key, so be sure to stay up-to-date on your HPV vaccinations and pap smears!

#AtTheForefront #CancerPrevention #CancerCare

Faubert honored at Winter Classic for cancer research | NHL.com University of Chicago professor receives V Scholar Award for work on lung cancer

Our Hem/Onc faculty in the media!! Dr. @faubert.bsky.social at the NHL Winter Classic in honor of his #HockeyFightsCancer grant www.nhl.com/news/univers... and Dr. Chen in the ASCO Post talking about her work in HR+/HER2- breast cancer ascopost.com/videos/2024-...

#AtTheForefront #CancerResearch

As Atty. Raymond Fortun piles up his celebrated cases, latest of which is the Cyberlibel case filed against Direk Darryl Yap, we'll get to know his real fortune—two young sons, both following their father's footsteps! Live #AtTheForefront with Atty. Karen Jimeno.

ASCO Election ASCO Election

Remember: voting for the ASCO Board of Directors closes on December 3rd and our fearless leader/Section Chief Dr. Soni Smith is on the ballot! Learn more & vote for Dr. Smith at society.asco.org/about-asco/a...
#ASCO #AtTheForefront #LeadershipMatters #OncSky

UChicagoCancer's Creator Profile

It is #PancreaticCancerAwarnessMonth! Learn more about how pancreatic cancer is detected & what early symptoms look like in our latest video on www.tiktok.com/@uchicagocan...

#UniversityofChicago #AtTheForefront #pancreaticcancer #cancerprevention

“Explain Cancer to Me” Comic Series | UCCCC Community Outreach and Engagement

Talking about cancer can be hard and complex. To make it a bit easier, check out our #graphicmedicine series "Explain Cancer to Me" for patient-friendly answers to FAQs: voices.uchicago.edu/communitycan...

#OncSky #MedSky #AtTheForefront #Cancer #PatientEducation